<DOC>
	<DOCNO>NCT01806207</DOCNO>
	<brief_summary>This study compare Durolane injection saline injection treatment unilateral osteoarthritis knee . The patient randomly assign one two treatment unaware treatment receive . The study conduct 13 center Germany , United Kingdom Sweden . Patients follow six week study treatment .</brief_summary>
	<brief_title>Durolane Compared Saline Patients With Unilateral Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Osteoarthritis accord ACR ( American College Radiology ) criteria knee WOMAC pain score range 7 17 Significant knee pain majority day past 3 month Patient normally active , bedridden confine wheelchair able walk 50 meter without help walker , crutch cane Patient attempt respond adequately nonpharmacological therapy ( y ) Patient cooperative able communicate effectively investigator Signed informed consent obtain Bilateral knee osteoarthritis Osteoarthritis clinically significant pain part musculoskeletal system study knee Kellgren Lawrence radiographic score grade IV study knee Change physical therapy/occupational therapy knee within last 3 month Treatment nonsteroidal antiinflammatory drug ( NSAIDs ) ( include topical agent study knee ) last week ( 5 halflives drug , whichever long ) prior baseline visit Treatment nonNSAID topicals capsaicin knee within last 3 day Intraarticular injection corticosteroid study knee within last 3 month Use systemic steroid ( exclude inhalation steroid ) within last 3 month Intraarticular injection hyaluronic acid study knee within last 9 month Treatment glucosamine/chondroitin sulfate within last 3 month Treatment pain reliever except paracetamol 4g/day Treatment anticoagulant ( except acetylsalicylic acid max . 325 mg/day ) Arthroscopy surgical procedure study knee within last 12 month Planned arthroscopy surgical procedure study period Any medical condition opinion investigator make patient unsuitable inclusion ( e.g . severe progressive chronic disease , malignancy , bleed disorder , fibromyalgia ) Systemic active inflammatory condition infection , Rheumatoid arthritis , inflammatory arthritis , ankylose spondylitis , psoriatic arthritis , reactive arthritis , gout/acute pseudogout connective tissue disease Septic arthritis study knee within last 3 month Active skin disease infection area injection site Significant venous lymphatic stasis present leg Pregnant breastfeed woman woman childbearing potential practicing adequate contraception Subjects opinion investigator unsuitable inclusion ( e.g . subject likely avoid therapy , subject likely stay study whole study period , subject likely unreliable ) Concurrent participation clinical study participation within precede 30 day</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>